Nemaura Medical Inc. (NMRD)
USD 0.0
(-50.0%)
USD 0.0
(-50.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.57 USD | -71.19% |
| 2022 | -0.59 USD | -110.71% |
| 2021 | -0.28 USD | -40.0% |
| 2020 | -0.20 USD | 20.0% |
| 2019 | -0.25 USD | -1966.12% |
| 2018 | -0.01 USD | -59.21% |
| 2017 | -0.01 USD | 0.0% |
| 2016 | -0.01 USD | -15.15% |
| 2015 | -0.01 USD | -127.59% |
| 2014 | -0.00 USD | 93.71% |
| 2013 | -0.05 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.09 USD | -582.58% |
| 2024 Q3 | -0.07 USD | -79.81% |
| 2024 Q2 | -0.04 USD | 53.83% |
| 2023 Q2 | -0.16 USD | 33.33% |
| 2023 FY | - USD | -71.19% |
| 2023 Q4 | -0.01 USD | 89.0% |
| 2023 Q3 | -0.12 USD | 25.0% |
| 2023 Q1 | -0.24 USD | 0.0% |
| 2022 Q4 | -0.24 USD | -60.0% |
| 2022 Q1 | -0.14 USD | -50.7% |
| 2022 Q2 | -0.15 USD | -7.14% |
| 2022 Q3 | -0.15 USD | 0.0% |
| 2022 FY | - USD | -110.71% |
| 2021 Q3 | -0.06 USD | 10.62% |
| 2021 FY | - USD | -40.0% |
| 2021 Q4 | -0.09 USD | -47.23% |
| 2021 Q1 | -0.05 USD | 18.55% |
| 2021 Q2 | -0.07 USD | -33.97% |
| 2020 Q2 | -0.05 USD | 10.8% |
| 2020 Q1 | -0.06 USD | 23.21% |
| 2020 FY | - USD | 20.0% |
| 2020 Q4 | -0.06 USD | -202.34% |
| 2020 Q3 | -0.02 USD | 60.15% |
| 2019 Q1 | -0.01 USD | 86.23% |
| 2019 FY | - USD | -1966.12% |
| 2019 Q4 | -0.08 USD | -1642.22% |
| 2019 Q3 | -0.00 USD | 19.64% |
| 2019 Q2 | -0.01 USD | 22.22% |
| 2018 Q4 | -0.05 USD | -1276.32% |
| 2018 Q3 | -0.00 USD | -100.0% |
| 2018 Q2 | -0.00 USD | 5.0% |
| 2018 Q1 | -0.00 USD | 88.57% |
| 2018 FY | - USD | -59.21% |
| 2017 FY | - USD | 0.0% |
| 2017 Q4 | -0.02 USD | -872.22% |
| 2017 Q3 | -0.00 USD | -12.5% |
| 2017 Q2 | -0.00 USD | 33.33% |
| 2017 Q1 | -0.00 USD | 88.24% |
| 2016 Q1 | -0.00 USD | 92.54% |
| 2016 FY | - USD | -15.15% |
| 2016 Q4 | -0.02 USD | -1175.0% |
| 2016 Q3 | -0.00 USD | 20.0% |
| 2016 Q2 | -0.00 USD | 0.0% |
| 2015 Q4 | -0.03 USD | -3250.0% |
| 2015 FY | - USD | -127.59% |
| 2015 Q1 | -0.00 USD | 83.95% |
| 2015 Q2 | -0.00 USD | -38.46% |
| 2015 Q3 | -0.00 USD | 55.56% |
| 2014 Q1 | -0.00 USD | 97.39% |
| 2014 Q3 | -0.00 USD | -1600.0% |
| 2014 Q4 | -0.01 USD | -376.47% |
| 2014 FY | - USD | 93.71% |
| 2014 Q2 | -0.00 USD | 66.67% |
| 2013 Q4 | -0.01 USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Acutus Medical, Inc. | -2.81 USD | 79.715% |
| Biotricity, Inc. | -1.66 USD | 65.663% |
| Cell MedX Corp. | -0.00 USD | -113900.0% |
| Dynatronics Corporation | -1.00 USD | 43.0% |
| PetVivo Holdings, Inc. | -0.78 USD | 26.923% |
| RetinalGenix Technologies Inc. | -0.12 USD | -375.0% |
| Sonendo, Inc. | -0.65 USD | 12.308% |
| Telesis Bio, Inc. | -1.64 USD | 65.244% |
| Talis Biomedical Corporation | -34.12 USD | 98.329% |
| Viveve Medical, Inc. | -2.65 USD | 78.491% |